Randomized clinical trials of hormone replacement therapy for treatment or prevention of cardiovascular disease: a review of the findings

被引:27
作者
Herrington, DM [1 ]
Klein, KP [1 ]
机构
[1] Wake Forest Univ, Bowman Gray Sch Med, Med Ctr, Dept Internal Med Cardiol, Winston Salem, NC 27157 USA
关键词
coronary heart disease; hormone replacement therapy; women; risk factors;
D O I
10.1016/S0021-9150(02)00202-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Coronary heart disease (CHD) is the leading cause of death in women. Epidemiologic, mechanistic, and animal-model studies have produced convincing evidence that hormone replacement therapy (HRT) could substantially decrease rates of CHD in women. However, several randomized clinical trials of HRT in women with CHID have been unable to confirm the earlier suggestions of benefit, and there has even been a suggestion of increased CHD risk. This article will review the findings to date of these long-term randomized clinical trials of HRT for prevention or treatment of CHD. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:203 / 212
页数:10
相关论文
共 62 条
[1]   Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis [J].
Adams, MR ;
Register, TC ;
Golden, DL ;
Wagner, JD ;
Williams, JK .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (01) :217-221
[2]   INHIBITION OF CORONARY-ARTERY ATHEROSCLEROSIS BY 17-BETA ESTRADIOL IN OVARIECTOMIZED MONKEYS - LACK OF AN EFFECT OF ADDED PROGESTERONE [J].
ADAMS, MR ;
KAPLAN, JR ;
MANUCK, SB ;
KORITNIK, DR ;
PARKS, JS ;
WOLFE, MS ;
CLARKSON, TB .
ARTERIOSCLEROSIS, 1990, 10 (06) :1051-1057
[3]  
*AM HEART ASS, 2001, HEART STROK STAT UPD
[4]   Effect of oral postmenopausal hormone replacement on progression of atherosclerosis -: A randomized, controlled trial [J].
Angerer, P ;
Störk, S ;
Kothny, W ;
Schmitt, P ;
von Schacky, C .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (02) :262-268
[5]  
[Anonymous], 1994, CIRCULATION
[6]   Raloxifene and cardiovascular events in osteoporotic postmenopausal women - Four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial [J].
Barrett-Connor, E ;
Grady, D ;
Sashegyi, A ;
Anderson, PW ;
Cox, DA ;
Hoszowski, K ;
Rautaharju, P ;
Harper, KD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (07) :847-857
[7]   ESTROGEN AND CORONARY HEART-DISEASE IN WOMEN [J].
BARRETTCONNOR, E ;
BUSH, TL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (14) :1861-1867
[8]   C-REACTIVE PROTEIN INDUCES HUMAN PERIPHERAL-BLOOD MONOCYTES TO SYNTHESIZE TISSUE FACTOR [J].
CERMAK, J ;
KEY, NS ;
BACH, RR ;
BALLA, J ;
JACOB, HS ;
VERCELLOTTI, GM .
BLOOD, 1993, 82 (02) :513-520
[9]   Estrogen receptor α mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen [J].
Chen, Z ;
Yuhanna, IS ;
Galcheva-Gargova, Z ;
Karas, RH ;
Mendelsohn, RE ;
Shaul, PW .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (03) :401-406
[10]  
Clarke S, 2000, EUR HEART J, V21, P212